| Product Code: ETC6197896 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In the Austria CIS insulin market, the import trend experienced a decline with a growth rate of -3.3% from 2023 to 2024. The compound annual growth rate (CAGR) for the period 2020-2024 stood at -10.36%. This negative import momentum may be attributed to shifting demand dynamics or changes in trade policies affecting market stability.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Austria CIS Insulin Market Overview |
3.1 Austria Country Macro Economic Indicators |
3.2 Austria CIS Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Austria CIS Insulin Market - Industry Life Cycle |
3.4 Austria CIS Insulin Market - Porter's Five Forces |
3.5 Austria CIS Insulin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Austria CIS Insulin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Austria CIS Insulin Market Revenues & Volume Share, By Source, 2021 & 2031F |
4 Austria CIS Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in the Austria CIS region |
4.2.2 Technological advancements in insulin delivery systems |
4.2.3 Growing awareness about the importance of diabetes management |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for insulin products |
4.3.2 High cost associated with insulin therapy |
4.3.3 Limited access to healthcare services in certain regions of Austria CIS |
5 Austria CIS Insulin Market Trends |
6 Austria CIS Insulin Market, By Types |
6.1 Austria CIS Insulin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Austria CIS Insulin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Austria CIS Insulin Market Revenues & Volume, By Type I Diabetes, 2021- 2031F |
6.1.4 Austria CIS Insulin Market Revenues & Volume, By Type II Diabetes, 2021- 2031F |
6.2 Austria CIS Insulin Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Austria CIS Insulin Market Revenues & Volume, By Rapid Acting, 2021- 2031F |
6.2.3 Austria CIS Insulin Market Revenues & Volume, By Long Acting, 2021- 2031F |
6.2.4 Austria CIS Insulin Market Revenues & Volume, By Short Acting, 2021- 2031F |
6.2.5 Austria CIS Insulin Market Revenues & Volume, By Intermediate Acting, 2021- 2031F |
6.2.6 Austria CIS Insulin Market Revenues & Volume, By Premixed, 2021- 2031F |
6.3 Austria CIS Insulin Market, By Source |
6.3.1 Overview and Analysis |
6.3.2 Austria CIS Insulin Market Revenues & Volume, By Analog, 2021- 2031F |
6.3.3 Austria CIS Insulin Market Revenues & Volume, By Human Recombinant, 2021- 2031F |
7 Austria CIS Insulin Market Import-Export Trade Statistics |
7.1 Austria CIS Insulin Market Export to Major Countries |
7.2 Austria CIS Insulin Market Imports from Major Countries |
8 Austria CIS Insulin Market Key Performance Indicators |
8.1 Number of insulin prescriptions filled |
8.2 Adoption rate of new insulin delivery devices |
8.3 Percentage of diabetic population with controlled blood sugar levels |
8.4 Investment in diabetes research and development |
8.5 Healthcare infrastructure development in the Austria CIS region |
9 Austria CIS Insulin Market - Opportunity Assessment |
9.1 Austria CIS Insulin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Austria CIS Insulin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Austria CIS Insulin Market Opportunity Assessment, By Source, 2021 & 2031F |
10 Austria CIS Insulin Market - Competitive Landscape |
10.1 Austria CIS Insulin Market Revenue Share, By Companies, 2024 |
10.2 Austria CIS Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |